Institutional Ownership Dyne Therapeutics, Inc. (DYN)
This table provides information about the institutional ownership of Dyne Therapeutics, Inc. (DYN). We have compiled data on the 227 institutions that hold shares in the stock, with a total of 148 Million shares, which have been reported (via 13F filing form) to have a value of $2.8 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
14,745,505
shares
|
$278 Million
0.09% of portfolio
|
Q3 2025
Added 56.24%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
9,760,414
shares
|
$184 Million
0.0% of portfolio
|
Q3 2025
Added 27.57%
|
|
|
Atlas Venture Life Science Advisors, LLC
|
Nov 13, 2025 Q3 2025 |
9,130,465
shares
|
$172 Million
26.07% of portfolio
|
Q1 2025
Added 13.86%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,386,988
shares
|
$139 Million
0.01% of portfolio
|
Q2 2024
Added 37.05%
|
|
|
Fcpm Iii Services B.V.
Naarden, P7 |
Nov 14, 2025 Q3 2025 |
5,462,846
shares
|
$103 Million
13.81% of portfolio
|
Q4 2024
Reduced 8.25%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
5,268,917
shares
|
$99.3 Million
0.0% of portfolio
|
Q3 2025
Added 57.01%
|
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2025 Q3 2025 |
4,729,174
shares
|
$89.1 Million
2.34% of portfolio
|
Q3 2025
Reduced 2.22%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
4,615,144
shares
|
$86.9 Million
6.54% of portfolio
|
Q3 2025
Added 22.53%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
3,554,000
shares
|
$67 Million
0.08% of portfolio
|
Q3 2025
Added 11.38%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
3,413,435
shares
|
$64.3 Million
0.01% of portfolio
|
Q3 2025
Added 261.64%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
3,365,245
shares
|
$63.4 Million
0.0% of portfolio
|
Q3 2025
Added 32.94%
|
|
|
Armistice Capital, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
3,064,000
shares
|
$57.7 Million
0.6% of portfolio
|
Q3 2025
Added 19.69%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
3,013,377
shares
|
$56.8 Million
0.04% of portfolio
|
Q3 2025
Added 572.92%
|
|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
2,890,567
shares
|
$54.5 Million
0.49% of portfolio
|
Q3 2025
Added 70.98%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
2,867,605
shares
|
$54 Million
0.0% of portfolio
|
Q3 2025
Added 27.24%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
2,812,422
shares
|
$53 Million
0.02% of portfolio
|
Q3 2025
Added 56.8%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
2,775,000
shares
|
$52.3 Million
1.59% of portfolio
|
Q3 2025
Added 281.44%
|
|
|
Braidwell LP
Stamford, CT |
Nov 14, 2025 Q3 2025 |
2,730,481
shares
|
$51.4 Million
1.99% of portfolio
|
Q3 2025
Reduced 16.58%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 14, 2025 Q3 2025 |
2,718,105
shares
|
$51.2 Million
1.45% of portfolio
|
Q3 2025
Added 80.49%
|
|
|
Saturn V Capital Management LLC
Austin, TX |
Nov 14, 2025 Q3 2025 |
2,674,469
shares
|
$50.4 Million
7.42% of portfolio
|
Q3 2025
Added 83.76%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
2,614,960
shares
|
$49.3 Million
5.26% of portfolio
|
Q3 2025
Added 134.53%
|
|
|
Logos Global Management LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
2,400,000
shares
|
$45.2 Million
3.51% of portfolio
|
Q3 2025
Added 26.32%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
2,314,184
shares
|
$43.6 Million
1.0% of portfolio
|
Q3 2025
Added 124.37%
|
|
|
Vr Adviser, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
2,173,913
shares
|
$41 Million
4.18% of portfolio
|
Q2 2023
New holding
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
2,000,000
shares
|
$37.7 Million
0.8% of portfolio
|
Q3 2025
New holding
|
|